NVGS Navigator
Navigator earnings company data as of 7:49 PM ET 10/23
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 0.40 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by NVGS's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $991K sold by 3 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Oeyvind Lindeman Chief Commercial OfficerSale$163K 7,500 shares at $21.68 51% of stakeTraded Aug 20 Filed Aug 24
-
Peter George Charles Andrew Stokes DirectorSale$101K 5,000 shares at $20.28 42% of stakeTraded Aug 12 Filed Aug 14
-
Oeyvind Lindeman Chief Commercial OfficerSale$136K 6,259 shares at $21.70 100% of stakeTraded May 29 Filed Jun 2
-
Michael Schroder COOSale$591K 25,000 shares at $23.63 83% of stakeTraded May 20 Filed May 22
Also filed in the last 12 months, not counted as buying or selling: 1 share withholding for taxes and 1 option exercise.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 6-K | Filing Doc | ||
| 6-K | Filing Doc | ||
| 424B7 | Filing Doc | ||
| 6-K | Filing Doc | ||
| 424B7 | Filing Doc | ||
| 20-F | Filing Doc | ||
| 6-K | Filing Doc | ||
| 6-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.